Education
About Us
Working with TipRanks
Follow Us
NexgenRx Inc (TSE:NXG)
:NXG
NXG Stock Chart & Stats
C$0.39
--
Market closed
C$0.39
--
Day’s Range― - ―
52-Week RangeC$0.23 - C$0.45
Previous CloseN/A
VolumeN/A
Average Volume (3M)11.32K
Market Cap
C$27.95M
Enterprise Value-C$2.90M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)24.4
Beta0.72
Next Earnings
Apr 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding71,117,134
10 Day Avg. Volume29,600
30 Day Avg. Volume11,325
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NexgenRx News
NXG FAQ
What was NexgenRx Inc’s price range in the past 12 months?
NexgenRx Inc lowest stock price was C$0.23 and its highest was C$0.45 in the past 12 months.
What is NexgenRx Inc’s market cap?
NexgenRx Inc’s market cap is C$27.95M.
When is NexgenRx Inc’s upcoming earnings report date?
NexgenRx Inc’s upcoming earnings report date is Apr 02, 2026 which is in 94 days.
How were NexgenRx Inc’s earnings last quarter?
NexgenRx Inc released its earnings results on Nov 21, 2025. The company reported C$0.008 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.008.
Is NexgenRx Inc overvalued?
According to Wall Street analysts NexgenRx Inc’s price is currently Overvalued.
Does NexgenRx Inc pay dividends?
NexgenRx Inc does not currently pay dividends.
What is NexgenRx Inc’s EPS estimate?
NexgenRx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NexgenRx Inc have?
NexgenRx Inc has 71,117,134 shares outstanding.
What happened to NexgenRx Inc’s price movement after its last earnings report?
NexgenRx Inc reported an EPS of C$0.008 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.5%.
Which hedge fund is a major shareholder of NexgenRx Inc?
Currently, no hedge funds are holding shares in TSE:NXG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NexgenRx Inc
NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.
Technical Analysis
Britannia Life Sciences Inc
―
Microbix Biosystms
―
Medicure
―
Nova Leap Health
―
Neupath Health Inc.
―